Teladoc Health, Inc. (NYSE:TDOC) Insider Sells $92,712.62 in Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Teladoc Health Stock Performance

Shares of NYSE TDOC traded up $0.26 during trading on Friday, reaching $8.43. 6,763,363 shares of the stock traded hands, compared to its average volume of 6,027,647. The company has a 50-day moving average of $10.45 and a 200-day moving average of $9.72. Teladoc Health, Inc. has a 52-week low of $6.76 and a 52-week high of $15.68. The stock has a market capitalization of $1.46 billion, a P/E ratio of -1.46 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of TDOC. Vanguard Group Inc. boosted its holdings in shares of Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock worth $167,830,000 after acquiring an additional 1,029,829 shares during the period. Point72 Asset Management L.P. lifted its holdings in Teladoc Health by 33.6% during the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock worth $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Teladoc Health by 15.5% in the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock worth $51,582,000 after purchasing an additional 763,265 shares during the period. Geode Capital Management LLC grew its holdings in Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock valued at $35,894,000 after buying an additional 22,664 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. grew its holdings in Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock valued at $32,369,000 after buying an additional 2,331,000 shares in the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on TDOC shares. The Goldman Sachs Group cut their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Monday, March 3rd. Piper Sandler cut their target price on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Bank of America lifted their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research report on Wednesday, February 12th. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $11.26.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.